Technical420 Site Search

) (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, are pleased to announce that: (i) Aphria has obtained an interim order (the " Interim Order ") of the Ontario Superior Court of Justice (Commercial List) (the " Court ") in connection with its proposed business combination with…

During the last year, we have seen a significant shift in how countries view medical and recreational cannabis. Over the course of this period, we have watched emerging markets advance and become multi-billion-dollar markets and is a trend that we are bullish on. Several Canadian Licensed Producers (LPs) have been…

Tilray, Inc . (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that it has received the necessary approvals from New Zealand's Ministry of Health and the Medicinal Cannabis Agency to launch Tilray medical cannabis products across the country. Tilray is one of the leading…

In any emerging market, one of the best ways to assess the progress of a new industry is through Wall Street analyst coverage. The cannabis sector is a prime example as we have seen a steady increase in the number of banks that are covering the industry. Although a majority…

For years, we have been highlighting the growth of the US cannabis market and continue to view it as a more attractive investment opportunity when compared to the Canadian market. During the last year, US cannabis operators have reported explosive growth, and this has caught the attention of several large…

So far this year, Tilray Inc. (TLRY) has been one of the most highly talked about Canadian cannabis companies and we attribute the spike in interest to the pending mega-merger with Aphria Inc. (APHA.TO) (APHA). Following the merger announcement, Tilray surged to the upside as the market started to recognize…

When compared to other mergers and acquisitions (M&A) in the cannabis industry, the Aphria Inc. (APHA.TO) (APHA) and Tilray, Inc. (TLRY) merger is one of the most significant transactions to be reported by the cannabis sector in recent years. We considered the combined company to be a leading play on…

Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today reported financial results for the full fiscal year and fourth quarter ended December 31, 2020. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. Brendan…

2021 has already proven to be a very active year for Tilray Inc. (TLRY) and we are not even halfway through February. So far this year, Tilray has rallied more than 100% and has been a top performing cannabis stock. Although the market became conditioned to Tilray’s volatile price swings…

Tilray Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced it has established an agreement with Grow Pharma to import and distribute Tilray’s medical cannabis products into the United Kingdom (UK). This agreement allows Tilray to provide authorized UK patients in need with a…